Table 3.
Antibiotic susceptibility pattern of Acinetobacter baumannii isolates
| Susceptibility pattern | COL | TGC | IMI | MER | CTZ | DFP | CTX | CIP | TET | PIP | SXT | AMP/S | AMK | GEN |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resistant | 71 (88.75) | 67 (83.75) | 63 (78.75) | 76 (95.0) | 77 (96.25) | 55 (72.5) | 74 (92.5) | 78 (97.5) | 80 (100) | 75 (93.75) | 64 (80.0) | 73 (91.25) | 35 (43.75) | 2 (2.5) |
| Intermediate | 0 | 0 | 0 | 2 (2.5) | 0 | 0 | 2 (2.5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Susceptible | 9 (11.25) | 13 (16.25) | 17 (21.25) | 2 (2.5) | 3 (3.75) | 25 (27.5) | 4 (5.0) | 2 (2.5) | 0 | 5 (6.25) | 16 (20) | 7 (8.75) | 45 (56.25) | 78 (97.5) |
Data are presented as n (%). AMK, amikacin; AMP/S, ampicillin/sulbactam; CFP, cefepime; CIP, ciprofloxacin; COL, colistin; CTX, cefotaxime; CTZ, ceftazidime; GEN, gentamicin; GEN, gentamicin; IMI, imipenem; LEV, levofloxacin; MEM, meropenem; MIN, minocycline; PIP, piperacillin; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; TGC, tigecycline; TGC, tigecycline; TOB, tobramycin.